Clinical Trials - Schopping Mool

Forte Biosciences, Inc. (FBRX) Shares Positive FB102 Phase 1b Vitiligo Study Results

Forte Biosciences, Inc. (FBRX) has announced positive results from its FB102 Phase 1b study focused on vitiligo, detailing the mechanism of action involved.

Editorial Staff about 6 hours ago

Money Stock Market

Teva Pharmaceutical Industries Limited Discusses Phase Ib Results of Anti-IL-15 Antibody for Vitiligo

Teva Pharmaceutical Industries Limited has shared the results of its Phase Ib trial for the Anti-IL-15 antibody, showing efficacy in treating vitiligo, and plans to move forward to Phase 2b.

Editorial Staff 4 days ago

Tech AI

Verge Labs Introduces AI Model to Improve Patient Stratification in Neurology Trials

Verge Labs has developed a novel AI solution aimed at enhancing patient stratification in neurology clinical trials, potentially reducing trial failures.

Editorial Staff 28 days ago

Life Medicine

Recent Developments in Parkinson's and Lung Cancer Therapies

Biogen and Denali's experimental treatment for Parkinson's disease has not achieved its trial objectives, while Merck's lung cancer therapy appears to offer potential benefits.

Editorial Staff about 2 months ago

#Clinical Trials

Forte Biosciences, Inc. (FBRX) Shares Positive FB102 Phase 1b Vitiligo Study Results

Teva Pharmaceutical Industries Limited Discusses Phase Ib Results of Anti-IL-15 Antibody for Vitiligo

Verge Labs Introduces AI Model to Improve Patient Stratification in Neurology Trials

Recent Developments in Parkinson's and Lung Cancer Therapies